Trends in Overall Mortality, and Timing and Cause of Death among Extremely Preterm Infants near the Limit of Viability
- Author(s)
- Jae Hyun Park; Yun Sil Chang; Sein Sung; So Yoon Ahn; Won Soon Park
- Keimyung Author(s)
- Park, Jae Hyun
- Department
- Dept. of Pediatrics (소아청소년학)
- Journal Title
- PloS One
- Issued Date
- 2017
- Volume
- 12
- Issue
- 1
- Abstract
- Objective;
To investigate the trends in mortality, as well as in the timing and cause of death, among
extremely preterm infants at the limit of viability, and thus to identify the clinical factors that
contribute to decreased mortality.
Methods;
We retrospectively reviewed the medical records of 382 infants born at 23±26 weeks' gestation;
124 of the infants were born between 2001 and 2005 (period I) and 258 were born
between 2006 and 2011 (period II). We stratified the infants into two subgroups±ª23±24
weeksº and ª25±26 weeksº±and retrospectively analyzed the clinical characteristics and mortality
in each group, as well as the timing and cause of death. Univariate and multivariate logistic
regression analyses were done to identify the clinical factors associated with mortality.
Results;
The overall mortality rate in period II was 16.7% (43/258), which was significantly lower than
that in period I (30.6%; 38/124). For overall cause of death, there were significantly fewer
deaths due to sepsis (2.4% [6/258] vs. 8.1% [10/124], respectively) and air-leak syndrome
(0.8% [2/258] vs. 4.8% (6/124), respectively) during period II than during period I. Among
the clinical factors of time period, 1-and 5-min Apgar score, antenatal steroid identified significant
by univariate analyses. 5-min Apgar score and antenatal steroid use were significantly
associated with mortality in multivariate analyses.
Conclusion;
Improved mortality rate attributable to fewer deaths due to sepsis and air leak syndrome in
the infants with 23±26 weeks' gestation was associated with higher 5-minute Apgar score
and more antenatal steroid use.
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.